Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Daiichi Sankyo
Merck
Harvard Business School
UBS
Julphar
Teva
Accenture
McKinsey
Chinese Patent Office

Generated: October 18, 2017

DrugPatentWatch Database Preview

Piperacillin sodium; tazobactam sodium - Generic Drug Details

« Back to Dashboard

What are the generic sources for piperacillin sodium; tazobactam sodium and what is the scope of piperacillin sodium; tazobactam sodium patent protection?

Piperacillin sodium; tazobactam sodium
is the generic ingredient in three branded drugs marketed by Istituto Bio Ita Spa, Hospira Inc, Wockhardt Bio Ag, Apollo Pharms Inc, Wyeth Pharms Inc, Sandoz Inc, Mylan Labs Ltd, Sandoz, and Aurobindo Pharma Ltd, and is included in fifteen NDAs. There are four patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Piperacillin sodium; tazobactam sodium has fifty-four patent family members in thirty-three countries.

There are fourteen drug master file entries for piperacillin sodium; tazobactam sodium. Thirteen suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: piperacillin sodium; tazobactam sodium

US Patents:4
Tradenames:3
Applicants:9
NDAs:15
Drug Master File Entries: see list14
Suppliers / Packagers: see list13
Clinical Trials: see list2,466
Therapeutic Class:Antibacterials
Drug Prices:see low prices
DailyMed Link:piperacillin sodium; tazobactam sodium at DailyMed

Pharmacology for Ingredient: piperacillin sodium; tazobactam sodium

Tentative approvals for PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Applicant Application No. Strength Dosage Form
u► Subscribe13.5G/VIALINJECTABLE;INJECTION
u► SubscribeEQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIALINJECTABLE;INJECTION
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Pharms Inc
ZOSYN
piperacillin sodium; tazobactam sodium
INJECTABLE;INJECTION050684-003Oct 22, 1993APRXYesYes► Subscribe► SubscribeY ► Subscribe
Wyeth Pharms Inc
ZOSYN IN PLASTIC CONTAINER
piperacillin sodium; tazobactam sodium
INJECTABLE;INJECTION050750-003Feb 24, 1998RXYesYes► Subscribe► SubscribeY ► Subscribe
Apollo Pharms Inc
PIPERACILLIN AND TAZOBACTAM
piperacillin sodium; tazobactam sodium
INJECTABLE;INJECTION207847-003Jan 13, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
PIPERACILLIN AND TAZOBACTAM
piperacillin sodium; tazobactam sodium
INJECTABLE;INJECTION065498-001May 23, 2011APRXNoNo► Subscribe► Subscribe► Subscribe
Wyeth Pharms Inc
ZOSYN
piperacillin sodium; tazobactam sodium
INJECTABLE;INJECTION050684-001Oct 22, 1993APRXYesYes► Subscribe► SubscribeY ► Subscribe
Wyeth Pharms Inc
ZOSYN IN PLASTIC CONTAINER
piperacillin sodium; tazobactam sodium
INJECTABLE;INJECTION050750-001Feb 24, 1998RXYesYes► Subscribe► SubscribeY ► Subscribe
Wyeth Pharms Inc
ZOSYN
piperacillin sodium; tazobactam sodium
INJECTABLE;INJECTION050684-002Oct 22, 1993APRXYesYes► Subscribe► SubscribeY ► Subscribe
Wyeth Pharms Inc
ZOSYN IN PLASTIC CONTAINER
piperacillin sodium; tazobactam sodium
INJECTABLE;INJECTION050750-001Feb 24, 1998RXYesYes► Subscribe► SubscribeY ► Subscribe
Wockhardt Bio Ag
PIPERACILLIN AND TAZOBACTAM
piperacillin sodium; tazobactam sodium
INJECTABLE;INJECTION206996-003Mar 22, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Wyeth Pharms Inc
ZOSYN
piperacillin sodium; tazobactam sodium
INJECTABLE;INJECTION050684-004Oct 22, 1993APRXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: piperacillin sodium; tazobactam sodium

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,498,312Compositions containing piperacillin and tazobactam useful for injection► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: piperacillin sodium; tazobactam sodium

Country Document Number Estimated Expiration
Japan2006523695► Subscribe
Argentina043863► Subscribe
Japan2006316075► Subscribe
World Intellectual Property Organization (WIPO)2004091666► Subscribe
Costa Rica9792► Subscribe
Taiwan200503758► Subscribe
World Intellectual Property Organization (WIPO)0050035► Subscribe
Israel171337► Subscribe
Austria381947► Subscribe
Switzerland695185► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Federal Trade Commission
McKinsey
AstraZeneca
US Department of Justice
Boehringer Ingelheim
Fish and Richardson
Deloitte
Express Scripts
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot